Treatment of Stable Angina with a New Fixed-Dose Combination of Ivabradine and Metoprolol: Effectiveness and Tolerability in Routine Clinical Practice

INTRODUCTION: In this prospective, multicenter, observational cohort study, the effectiveness and tolerability of the first fixed-dose combination (FDC) formulation of the selective heart rate reducing agent ivabradine and the beta-blocker metoprolol was evaluated in stable angina pectoris (AP) pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Divchev, Dimitar, Stöckl, Georg
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688976/
https://www.ncbi.nlm.nih.gov/pubmed/29116618
http://dx.doi.org/10.1007/s40119-017-0099-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688976/
https://www.ncbi.nlm.nih.gov/pubmed/29116618
http://dx.doi.org/10.1007/s40119-017-0099-1

Ejemplares similares